期刊文献+

肠道菌群在炎症性肠病发病机制中作用的研究进展 被引量:8

Research progress of the role of intestinal flora in pathogenesis of inflammatory bowel disease
原文传递
导出
摘要 炎症性肠病(inflammatory bowel disease,BD)是一类免疫相关性肠道疾病,包括溃疡性结肠炎(ulcerative colitis,UC)、克罗恩病(Crohn’s disease,CD)、未定型结肠炎(indeterminate colitis,IC)3类,其病因和发病机制至今不明,多数研究推测其发病可能与肠道黏膜的免疫系统异常反应、环境因素、遗传易感性和肠道菌群改变等相关。为进一步明确肠道菌群失调与IBD发病机制的相关性,本文就IBD患者肠道菌群失调特征与其可能的发生发展机制进行综述。 Inflammatory bowel disease(IBD)is an immune-related intestinal inflammatory disease,which is clinically divided into 3 categories:ulcerative colitis(UC),Crohn’s disease(CD),and indeterminate colitis(IC).Although its pathogenesis is still unclear,most studies speculate that the pathogenesis of IBD has the relation with the abnormal response of intestinal mucosal immune system,environmental factors,genetic susceptibility and intestinal flora dysbiosis.In recent years,the relationship between intestinal flora dysbiosis and the pathogenesis of IBD has become a research hotspot.Therefore,this article reviews the characteristics of intestinal flora dysbiosis and its possible mechanism in patients with IBD.
作者 陈娇娇 周莹群 CHEN Jiao-jiao;ZHOU Ying-qun(Department of Gastroenterology,Shanghai Tenth People’s Hospital of Tongji University,Shanghai 200072,China)
出处 《世界临床药物》 CAS 2019年第5期324-328,共5页 World Clinical Drug
基金 上海市第十人民医院国家自然培育基金项目(编号:SYGZRPY2017003)
关键词 炎症性肠病 肠道菌群 发病机制 inflammatory bowel disease intestinal flora microbiota pathogenesis
  • 相关文献

参考文献2

二级参考文献55

  • 1Peter Laszlo Lakatos.Recent trends in the epidemiology of inflammatory bowel diseases:Up or down?[J].World Journal of Gastroenterology,2006,12(38):6102-6108. 被引量:47
  • 2Huang JS, Noack D, Rae J, Ellis BA, Newbury R, Pong AL, Lavine JE, Curnutte JT, Bastian J. Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease. Clin Gastroenterol Hepatol 2004; 2:690-695. 被引量:1
  • 3Schinella RA, Greco MA, Cobert BL, Denmark LW, Cox RP. Hermansky-Pudlak syndrome with granulomatous colitis. Ann Intern Med 1980; 92:20-23. 被引量:1
  • 4Dieckgraefe BK, Korzenik JR. Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 2002; 360:1478-1480. 被引量:1
  • 5Fuss iJ, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S, Yang Z, Exley M, Kitani A, Blumberg KS, Mannon P, Strober W. Nonclassical CDld-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 2004; 113:1490-1497. 被引量:1
  • 6Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157: 1261-1270. 被引量:1
  • 7Kobayashi K, Kaneda K, Kasama T. Immunopathogenesis of delayed-type hypersensitivity. Microsc Res Tech 2001; 53: 241-245. 被引量:1
  • 8Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25:821-852. 被引量:1
  • 9Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8:967-974. 被引量:1
  • 10Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52:65-70. 被引量:1

共引文献55

同被引文献109

引证文献8

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部